IRIS Accounts Production v25.3.0.601 09521668 Board of Directors 1.4.24 31.3.25 31.3.25 Medium entities true true false true true false false true true true true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Fair value model Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh095216682024-03-31095216682025-03-31095216682024-04-012025-03-31095216682023-03-31095216682023-04-012024-03-31095216682024-03-3109521668ns15:EnglandWales2024-04-012025-03-3109521668ns14:PoundSterling2024-04-012025-03-3109521668ns10:Director12024-04-012025-03-3109521668ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3109521668ns10:MediumEntities2024-04-012025-03-3109521668ns10:Audited2024-04-012025-03-3109521668ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-04-012025-03-3109521668ns10:Medium-sizedCompaniesRegimeForAccounts2024-04-012025-03-3109521668ns10:FullAccounts2024-04-012025-03-3109521668ns10:OrdinaryShareClass12024-04-012025-03-3109521668ns10:Director22024-04-012025-03-3109521668ns10:RegisteredOffice2024-04-012025-03-3109521668ns5:CurrentFinancialInstruments2025-03-3109521668ns5:CurrentFinancialInstruments2024-03-3109521668ns5:Non-currentFinancialInstruments2025-03-3109521668ns5:Non-currentFinancialInstruments2024-03-3109521668ns5:ShareCapital2025-03-3109521668ns5:ShareCapital2024-03-3109521668ns5:RetainedEarningsAccumulatedLosses2025-03-3109521668ns5:RetainedEarningsAccumulatedLosses2024-03-3109521668ns5:ShareCapital2023-03-3109521668ns5:RetainedEarningsAccumulatedLosses2023-03-3109521668ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-3109521668ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-310952166812024-04-012025-03-310952166812024-04-012025-03-310952166812023-04-012024-03-3109521668ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2024-04-012025-03-3109521668ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-04-012024-03-3109521668ns5:OwnedAssets2024-04-012025-03-3109521668ns5:OwnedAssets2023-04-012024-03-3109521668ns5:HirePurchaseContracts2024-04-012025-03-3109521668ns5:HirePurchaseContracts2023-04-012024-03-3109521668ns10:OrdinaryShareClass12023-04-012024-03-3109521668ns5:FurnitureFittings2024-03-3109521668ns5:MotorVehicles2024-03-3109521668ns5:FurnitureFittings2024-04-012025-03-3109521668ns5:MotorVehicles2024-04-012025-03-3109521668ns5:FurnitureFittings2025-03-3109521668ns5:MotorVehicles2025-03-3109521668ns5:FurnitureFittings2024-03-3109521668ns5:MotorVehicles2024-03-3109521668ns5:CostValuation2024-03-3109521668ns5:Subsidiary12024-04-012025-03-31095216681ns5:Subsidiary12024-04-012025-03-3109521668ns5:Subsidiary22024-04-012025-03-3109521668ns5:Subsidiary232024-04-012025-03-3109521668ns5:Subsidiary32024-04-012025-03-31095216685ns5:Subsidiary32024-04-012025-03-3109521668ns5:Subsidiary42024-04-012025-03-3109521668ns5:Subsidiary472024-04-012025-03-3109521668ns5:Subsidiary52024-04-012025-03-31095216689ns5:Subsidiary52024-04-012025-03-3109521668ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3109521668ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3109521668ns5:CurrentFinancialInstruments2024-04-012025-03-3109521668ns5:Non-currentFinancialInstruments2024-04-012025-03-3109521668ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-03-3109521668ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-03-3109521668ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-03-3109521668ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-3109521668ns5:DeferredTaxation2024-03-3109521668ns5:DeferredTaxation2024-04-012025-03-3109521668ns5:DeferredTaxation2025-03-3109521668ns10:OrdinaryShareClass12025-03-3109521668ns5:RetainedEarningsAccumulatedLosses2024-03-310952166812024-04-012025-03-31
REGISTERED NUMBER: 09521668 (England and Wales)















STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

ROTHERWOOD HEALTHCARE LIMITED

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 6

Statement of Comprehensive Income 9

Balance Sheet 10

Statement of Changes in Equity 11

Notes to the Financial Statements 12


ROTHERWOOD HEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







Directors: R C Claridge
J P F Fennell





Registered office: 11 Merus Court
Meridian Business Park
Leicester
LE19 1RJ





Registered number: 09521668 (England and Wales)





Auditors: TC Group
1 Merus Court
Meridian Business Park
Leicester
LE19 1RJ

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025

The directors present their strategic report for the year ended 31 March 2025.

Review of business
The Company has delivered a satisfactory result for the current period. The Company continues its capital investment programme to ensure it can maintain value for service users.

Principal risks and uncertainties
The management of the business and the execution of the Company's strategy are subject to a number of risks. Risks are formally reviewed by the board and appropriate processes are put in place to monitor and mitigate them.

The key business risks affecting the Company are set out below:

Credit Risk
New credit service users are only accepted after they have been approved by the credit controller. The Company undertakes perpetual review processes to make sure debts are collected in a timely manner.

Liquidity Risk
The Company is currently financed with short-term finance. The parent company has appropriate long-term finance to provide the support required to match the needs of the business.

Financial key performance indicators
Key performance indicators used by the Company are as follows:

- Turnover;
- Gross profit margin; and
- Profit on ordinary activities before taxation.

During the year turnover has increased by £529,845 (121%) to £969,397 compared to £439,552 in 2024.

During the year gross profit has increased by £732,466 (153%) to £254,468 compared to (£477,998) in 2024.

During the year profit before tax decreased by £7,171,412 (91%) to £680,516 compared to £7,851,928 in 2024.

On behalf of the board:





J P F Fennell - Director


24 December 2025

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 MARCH 2025

The directors present their report with the financial statements of the company for the year ended 31 March 2025.

Principal activity
The principal activity of the company during the year continued to be that of a property management company.

Results
The profit for the year, after taxation, amounted to £459,473 (2024: £6,748,231).

Dividends
During the year the Company paid dividends totalling £8,968,013 (2024 - £3,500,000).

This was made up of a dividend in specie, which was satisfied by the transfer of the Company's investment property on 28 November 2024. The distribution was made in accordance with the Companies Act 2006 and the Company's articles.

Future developments
Going forward the directors aim to continue to grow the business whilst keeping tight control over costs.

Events since the end of the year
Information relating to events since the end of the year is given in the notes to the financial statements.

Directors
The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report.

R C Claridge
J P F Fennell


ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 MARCH 2025

Going concern
The financial statements show net assets of £4,790,056, net current liabilities of £4,445,671 and profit of £459,473.

During the prior year, the Parent Group, of which the Company is a subsidiary ("Parent Group"), identified an error in the treatment of VAT within Rotherwood Training and Development Limited following the implementation of Welfare Contract Restructuring, resulting in the submission of a voluntary disclosure and error correction to HMRC. Rotherwood Training and Development Limited is a 100% subsidiary of Rotherwood Group Limited and a member of the VAT group to which the Company belongs. The VAT liability is recoverable against all companies within the VAT group on a joint and several basis. Within the Parent Group’s financial statements are obligations of £5,357,905 relating to VAT due within one year.

Post year end, the Company has been cash generative and profitable, with strong underlying trading performance. The only factor affecting the assessment of going concern of the Company is the joint and several nature of the legacy VAT liability and other tax liabilities.

The Parent Group maintained sufficient cash flows during 2024 and 2025 to meet its liabilities. While cash outflows over the next 12 months are expected to reflect the settlement of VAT and other tax liabilities, as well as associated interest and potential penalties, the Parent Group has already taken significant steps to strengthen its financial position and liquidity.

To further strengthen its Balance Sheet, the Parent Group, via a separate sub-group, secured a £5,500,000 loan facility, supported by unencumbered real estate assets. Simultaneously, it is progressing the sale of non core landholdings, anticipated to generate around £2,000,000 to reinvest in priority projects and provide additional financial resilience.

The Directors of the Parent Group have prepared detailed monthly cash flow forecasts through to 31 March 2028. These forecasts include sensitivity analysis under various downside and upside scenarios, considering both operational risks and growth opportunities. Across the most reasonably foreseeable scenarios, the forecasts demonstrate adequate headroom, assuming the ability to match the timing of cash flows through the successful completion of either the additional bank funding or the agreement of a suitable repayment plan with HMRC. A letter of support has been provided which confirms the Group’s commitment to each entity within the Group to provide such support as is required to enable each entity to continue as a going concern for a period of 12 months from the date of approval of the financial statements for the year ended 31 March 2025. This support will be provided if such a need arises. The letter also confirms that intercompany balances across the Group will not be recalled until each respective entity is in a financial position to make such repayments without jeopardising its own operational or financial stability and ability to continue to trade.

On the basis of these forecasts, the Group letter of support and the steps already underway to strengthen liquidity, the directors have a reasonable expectation that the VAT liability will be settled by other companies within the group and that the company will have sufficient resources to continue and meet its liabilities as they fall due, and for a period of at least 12 months from the date of approval of these financial statements.

Accordingly, the financial statements have been prepared on a going concern basis.

Statement of directors' responsibilities
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.


ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 MARCH 2025

Statement of directors' responsibilities - continued
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement as to disclosure of information to auditors
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

Auditors
The auditors, TC Group, will be proposed for re-appointment at the forthcoming Annual General Meeting.

On behalf of the board:





J P F Fennell - Director


24 December 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ROTHERWOOD HEALTHCARE LIMITED

Opinion
We have audited the financial statements of Rotherwood Healthcare Limited (the 'company') for the year ended 31 March 2025 which comprise the Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ROTHERWOOD HEALTHCARE LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on pages four and five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ROTHERWOOD HEALTHCARE LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Extent to which the audit was considered capable of detecting irregularities, including fraud

The objectives of our audit, in respect to fraud, are: to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses; and to respond appropriately to fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both those charged with governance of the entity and its management.

Our approach was as follows:

- Enquiry of management and those charged with governance around actual, potential or suspected litigation,
claims, non-compliance with applicable laws and regulations and fraud.
- Enquiry of entity staff in tax and compliance functions and external advisors to identify any instances of
non-compliance with laws and regulations.
- Performing audit work over the risk of management override, including testing of journal entries and other
adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal
course of business and reviewing the accounting estimates for bias.
- Reviewing of financial statement disclosures and testing to supporting documentation to assess compliance with
applicable laws and regulations.
- Discussions amongst the engagement team in relation to how and where fraud might occur in the financial
statements and any potential indicators of fraud.
- Reviewing minutes of meetings during the year.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Shiran Wynter (ACA) (Senior Statutory Auditor)
for and on behalf of TC Group
1 Merus Court
Meridian Business Park
Leicester
LE19 1RJ

24 December 2025

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

STATEMENT OF COMPREHENSIVE
INCOME
FOR THE YEAR ENDED 31 MARCH 2025

2025 2024
Notes £ £

Turnover 4 969,397 439,552

Cost of sales 714,929 917,550
Gross profit/(loss) 254,468 (477,998 )

Administrative expenses 742,633 545,663
(488,165 ) (1,023,661 )

Other operating income 5 1,490,730 1,467,703
Gain/loss on revaluation of investment
property

-

3,917,151
Operating profit 8 1,002,565 4,361,193

Income from shares in group undertakings 10 - 3,500,000
1,002,565 7,861,193

Interest payable and similar expenses 11 322,049 9,265
Profit before taxation 680,516 7,851,928

Tax on profit 12 221,043 1,103,697
Profit for the financial year 459,473 6,748,231

Other comprehensive income - -
Total comprehensive income for the year 459,473 6,748,231

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £ £
Fixed assets
Tangible assets 14 538,525 607,398
Investments 15 1,160,160 1,160,160
Investment property 16 23,023,322 31,572,767
24,722,007 33,340,325

Current assets
Debtors 17 9,205,192 8,618,505
Cash at bank 54,373 1,100
9,259,565 8,619,605
Creditors
Amounts falling due within one year 18 (13,705,236 ) (24,936,378 )
Net current liabilities (4,445,671 ) (16,316,773 )
Total assets less current liabilities 20,276,336 17,023,552

Creditors
Amounts falling due after more than one
year

19

(11,769,397

)

(81,471

)

Provisions for liabilities 21 (3,716,883 ) (3,643,485 )
Net assets 4,790,056 13,298,596

Capital and reserves
Called up share capital 22 100 100
Retained earnings 23 4,789,956 13,298,496
Shareholders' funds 4,790,056 13,298,596

The financial statements were approved by the Board of Directors and authorised for issue on 24 December 2025 and were signed on its behalf by:





J P F Fennell - Director


ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025

Called up
share Retained Total
capital earnings equity
£ £ £
Balance at 1 April 2023 100 10,050,265 10,050,365

Changes in equity
Dividends - (3,500,000 ) (3,500,000 )
Total comprehensive income - 6,748,231 6,748,231
Balance at 31 March 2024 100 13,298,496 13,298,596

Changes in equity
Dividends - (8,968,013 ) (8,968,013 )
Total comprehensive income - 459,473 459,473
Balance at 31 March 2025 100 4,789,956 4,790,056

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1. STATUTORY INFORMATION

Rotherwood Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

After reviewing the Company's forecasts and projections, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. The Company therefore continues to adopt the going concern basis in preparing its financial statements.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgements in applying the Company's accounting policies (see note 3).

Financial Reporting Standard 102 - reduced disclosure exemptions
The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

the requirements of Section 7 Statement of Cash Flows;
the requirement of paragraph 3.17(d);
the requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and
11.48(c);
the requirements of paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and 12.29A;
the requirement of paragraph 33.7.

This information is included in the consolidated financial statements of Rotherwood Group Limited, registration number 09519658, as at 31 March 2025 and these financial statements may be obtained from 11 Merus Court, Meridian Business Park, Leicester, LE19 1RJ.

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Going concern
The financial statements show net assets of £4,790,056, net current liabilities of £4,445,671 and profit of £459,473.

During the prior year, the Parent Group, of which the Company is a subsidiary ("Parent Group"), identified an error in the treatment of VAT within Rotherwood Training and Development Limited following the implementation of Welfare Contract Restructuring, resulting in the submission of a voluntary disclosure and error correction to HMRC. Rotherwood Training and Development Limited is a 100% subsidiary of Rotherwood Group Limited and a member of the VAT group to which the Company belongs. The VAT liability is recoverable against all companies within the VAT group on a joint and several basis. Within the Parent Group’s financial statements are obligations of £5,357,905 relating to VAT due within one year.

Post year end, the Company has been cash generative and profitable, with strong underlying trading performance. The only factor affecting the assessment of going concern of the Company is the joint and several nature of the legacy VAT liability and other tax liabilities.

The Parent Group maintained sufficient cash flows during 2024 and 2025 to meet its liabilities. While cash outflows over the next 12 months are expected to reflect the settlement of VAT and other tax liabilities, as well as associated interest and potential penalties, the Parent Group has already taken significant steps to strengthen its financial position and liquidity.

To further strengthen its Balance Sheet, the Parent Group, via a separate sub-group, secured a £5,500,000 loan facility, supported by unencumbered real estate assets. Simultaneously, it is progressing the sale of non core landholdings, anticipated to generate around £2,000,000 to reinvest in priority projects and provide additional financial resilience.

The Directors of the Parent Group have prepared detailed monthly cash flow forecasts through to 31 March 2028. These forecasts include sensitivity analysis under various downside and upside scenarios, considering both operational risks and growth opportunities. Across the most reasonably foreseeable scenarios, the forecasts demonstrate adequate headroom, assuming the ability to match the timing of cash flows through the successful completion of either the additional bank funding or the agreement of a suitable repayment plan with HMRC. A letter of support has been provided which confirms the Group’s commitment to each entity within the Group to provide such support as is required to enable each entity to continue as a going concern for a period of 12 months from the date of approval of the financial statements for the year ended 31 March 2025. This support will be provided if such a need arises. The letter also confirms that intercompany balances across the Group will not be recalled until each respective entity is in a financial position to make such repayments without jeopardising its own operational or financial stability and ability to continue to trade.

On the basis of these forecasts, the Group letter of support and the steps already underway to strengthen liquidity, the directors have a reasonable expectation that the VAT liability will be settled by other companies within the group and that the company will have sufficient resources to continue and meet its liabilities as they fall due, and for a period of at least 12 months from the date of approval of these financial statements.

Accordingly, the financial statements have been prepared on a going concern basis.

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services
Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
-the amount of revenue can be measured reliably;
-it is probable that the Company will receive the consideration due under the contract;
-the stage of completion of the contract at the end of the reporting period can be measured reliably; and
-the costs incurred and the costs to complete the contract can be measured reliably.

Operating leases: the Company as the lessee
Rentals paid under operating leases are charged to the Statement of Comprehensive Income on a straight-line basis over the lease term.

Leased assets: the Company as lessee
Assets obtained under hire purchase contracts and finance leases are capitalised as tangible fixed assets. Assets acquired by finance lease are depreciated over the shorter of the lease term and their useful lives. Assets acquired by hire purchase are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the Company. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the Statement of Comprehensive Income so as to produce a constant periodic rate of charge on the net obligation outstanding in each year.

Finance costs
Finance costs are charged to the Statement of Comprehensive Income over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

The Company adds to the carrying amount of an item of fixed assets the cost of replacing part of such an item when that cost is incurred, if the replacement part is expected to provide incremental future benefits to the Company. The carrying amount of the replaced part is derecognised. Repairs and maintenance are charged to the Statement of Comprehensive Income during the period in which they are incurred.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance or straight line basis.

Depreciation is provided on the following basis:

Motor vehicles-25% straight line
Fixtures and fittings-20% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Comprehensive Income.

Provisions for liabilities
Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.

Provisions are charged as an expense to the Statement of Comprehensive Income in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account the relevant risks and uncertainties.

When payments are eventually made, they are charged to the provision carried in the Balance Sheet

Investments in subsidiaries
Investments in subsidiaries are measured at cost less accumulated impairment.

Investment property
Investment property is carried at fair value determined by external valuers and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in nature, location or condition of the specific asset. No depreciation is provided. Changes in fair value are recognised in the Statement of Comprehensive Income.

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
The Company has elected to apply the provisions of Section 11 "Basic Financial Instruments" of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Other financial assets
Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Impairment of financial assets
Financial assets are assessed for indicators of impairment at each reporting date.

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the Statement of Comprehensive Income.

Financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.


ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued
Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Other financial instruments
Derivatives, including forward exchange contracts, futures contracts and interest rate swaps, are not classified as basic financial instruments. These are initially recognised at fair value on the date the derivative contract is entered into, with costs being charged to the profit or loss. They are subsequently measured at fair value with changes in the Statement of Comprehensive Income.

Debt instruments that do not meet the conditions as set out in FRS 102 paragraph 11.9 are subsequently measured at fair value through the Statement of Comprehensive Income. This recognition and measurement would also apply to financial instruments where the performance is evaluated on a fair value basis as with a documented risk management or investment strategy.

Derecognition of financial instruments

Derecognition of financial assets
Financial assets are derecognised when their contractual right to future cash flows expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities
Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Current and deferred taxation
The tax expense for the year comprises current and deferred tax. Tax is recognised in the Statement of Comprehensive Income except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
-The recognition of deferred tax assets is limited to the extent that it is probable that they will be
recovered against the reversal of deferred tax liabilities or other future taxable profits; and
-Any deferred tax balances are reversed if and when all conditions for retaining associated tax
allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Defined contribution pension plan
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in the Statement of Comprehensive Income when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at transaction price, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at transaction price, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Holiday pay accrual
A liability is recognised to the extent of any unused holiday pay entitlement which is accrued at the balance sheet date and carried forward to future periods. This is measured at the undiscounted salary cost of the future holiday entitlement so accrued at the balance sheet date.

Dividends
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

3. CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

The Company makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimates and assumptions that have significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are addressed below:

i) Useful economic lives of tangible assets
The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are reassessed annually. They are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of the assets.

ii) Impairment of assets
The Company makes an estimate of the recoverable value of assets. When assessing impairment of assets, management considers factors including the current credit rating of the debtor, the ageing profile of the debtors and historical experience, and in the case of intercompany debtors, the trading performance and cash generation expectations of the subsidiary to enable it to clear the debt.

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

4. TURNOVER

An analysis of turnover by class of business is as follows:

20252024
£   £   

Management charges869,397-
Rental income100,000439,552
969,397439,552


All turnover arose within the United Kingdom.

5. OTHER OPERATING INCOME
2025 2024
£ £
Rents received 20,730 27,703
Fees receivable 1,470,000 1,440,000
1,490,730 1,467,703

6. EMPLOYEES AND DIRECTORS

There were no staff costs for the year ended 31 March 2025 nor for the year ended 31 March 2024.

The average number of employees during the year was as follows:
2025 2024

All staff 2 2

7. DIRECTORS' EMOLUMENTS

During the year, no director received any emoluments.

8. OPERATING PROFIT

The operating profit is stated after charging:

2025 2024
£ £
Hire of plant and machinery 11,139 12,267
Depreciation - owned assets 167,526 187,988
Loss on disposal of fixed assets 8,534 11,632

9. AUDITORS' REMUNERATION

During the period, fees payable to the Company's auditors for the audit of the Company's financial statements totalled £7,000. (2024: £7,000)

The Company has taken advantage of the exemption not to disclose amounts paid for non-audit services as these are disclosed in the consolidated accounts of the parent Company.

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

10. INCOME FROM SHARES IN GROUP UNDERTAKINGS
2025 2024
£ £
Shares in group undertakings - 3,500,000

11. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£ £
Bank loan interest 297,927 -
Hire purchase 24,122 9,265
322,049 9,265

12. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2025 2024
£ £
Current tax:
UK corporation tax 147,645 1,103,697

Deferred tax 73,398 -
Tax on profit 221,043 1,103,697

UK corporation tax has been charged at 25% .

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£ £
Profit before tax 680,516 7,851,928
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2024 - 25%)

170,129

1,962,982

Effects of:
Expenses not deductible for tax purposes 4,229 1,327
Income not taxable for tax purposes - (875,000 )
Capital allowances in excess of depreciation (28,847 ) (19,997 )
Adjustments to tax charge in respect of previous periods - 31,477
Qualifying profit/loss on disposal - 2,908
Non qualifying profit/loss on disposal 2,134 -
Deferred tax adjustment 73,398 -
Total tax charge 221,043 1,103,697

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

13. DIVIDENDS
2025 2024
£ £
Ordinary shares of 1 each
Final 8,968,013 3,500,000

14. TANGIBLE FIXED ASSETS
Fixtures
and Motor
fittings vehicles Totals
£ £ £
Cost
At 1 April 2024 830,167 345,469 1,175,636
Additions - 113,230 113,230
Disposals - (39,432 ) (39,432 )
At 31 March 2025 830,167 419,267 1,249,434
Depreciation
At 1 April 2024 435,083 133,155 568,238
Charge for year 98,679 68,847 167,526
Eliminated on disposal - (24,855 ) (24,855 )
At 31 March 2025 533,762 177,147 710,909
Net book value
At 31 March 2025 296,405 242,120 538,525
At 31 March 2024 395,084 212,314 607,398

15. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£
Cost
At 1 April 2024
and 31 March 2025 1,160,160
Net book value
At 31 March 2025 1,160,160
At 31 March 2024 1,160,160

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Rotherwood Healthcare (Lynhales Hall) Limited
Registered office: 11 Merus Court, Leicester, England, LE19 1RJ
Nature of business: Care to the elderly and mentally infirm
%
Class of shares: holding
Ordinary 100.00

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

15. FIXED ASSET INVESTMENTS - continued

Rotherwood Healthcare (Hampton Grange) Limited
Registered office: 11 Merus Court, Leicester, England, LE19 1RJ
Nature of business: Care of the elderly and mentally infirm
%
Class of shares: holding
Ordinary 100.00

Rotherwood Healthcare (Dorset House) Limited
Registered office: 11 Merus Court, Leicester, England, LE19 1RJ
Nature of business: Care of the elderly and mentally infirm
%
Class of shares: holding
Ordinary 100.00

Rotherwood Healthcare (St Georges Park) Limited
Registered office: 11 Merus Court, Leicester, England, LE19 1RJ
Nature of business: Care of the elderly and mentally infirm
%
Class of shares: holding
Ordinary 100.00

Rotherwood Healthcare (Waterside) Limited
Registered office: 11 Merus Court, Leicester, England, LE19 1RJ
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00

16. INVESTMENT PROPERTY
Total
£
Fair value
At 1 April 2024 31,572,767
Additions 418,568
Disposals (8,968,013 )
At 31 March 2025 23,023,322
Net book value
At 31 March 2025 23,023,322
At 31 March 2024 31,572,767

Freehold investment properties were revalued on 13th June 2024. The valuation was completed by Cushman & Wakefield.

The directors have confirmed that there are no other changes in the valuation as at 31 March 2025.

If the Investment properties had been accounted for under the historic cost accounting rules, the properties would have been measured at £8,535,103 (2024 - £17,084,548).

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

17. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Amounts owed by group undertakings 8,970,619 8,371,245
Other debtors 219,983 234,253
Prepayments and accrued income 14,590 13,007
9,205,192 8,618,505

18. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Bank loans and overdrafts (see note 20) 1,218,693 -
Trade creditors 68,236 70,873
Amounts owed to group undertakings 11,844,488 23,481,808
Tax 175,569 189,722
Other creditors 313,877 1,131,486
Obligations under finance lease and hire
purchase contracts

84,373

62,489
13,705,236 24,936,378

Net obligations under hire purchase contracts of £84,373 (2024 - £62,489) are secured against the assets of the Company.

Triodos Bank UK Limited hold fixed and floating charges over all property and undertakings of the Company.

19. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£ £
Bank loans (see note 20) 11,673,003 -
Net obligations under finance leases and hire
purchase contracts

96,394

81,471
11,769,397 81,471

Net obligations under hire purchase contracts of £96,394 (2024 - £81,471) are secured against the assets of the Company.

Triodos Bank UK Limited hold fixed and floating charges over all property and undertakings of the Company.

20. LOANS

An analysis of the maturity of loans is given below:

2025 2024
£ £
Amounts falling due within one year or on demand:
Bank loans 1,218,693 -

Amounts falling due between one and two years:
Bank loans - 1-2 years 1,218,693 -

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

20. LOANS - continued
2025 2024
£ £
Amounts falling due between two and five years:
Bank loans - 2-5 years 3,656,080 -

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 6,798,230 -

21. PROVISIONS FOR LIABILITIES
2025 2024
£ £
Deferred tax 3,716,883 3,643,485

Deferred tax
£
Balance at 1 April 2024 3,643,485
Charge to Statement of Comprehensive Income during year 73,398
Balance at 31 March 2025 3,716,883

22. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £ £
100 Ordinary 1 100 100

23. RESERVES
Retained
earnings
£

At 1 April 2024 13,298,496
Profit for the year 459,473
Dividends (8,968,013 )
At 31 March 2025 4,789,956

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

24. CONTINGENT LIABILITIES

During the year, the Parent Group, of which the Company is a subsidiary ("Parent Group") identified an error in the treatment of VAT within Rotherwood Training and Development Limited, a fellow group company, following the implementation of Welfare Contract Restructuring, resulting in the submission of a voluntary disclosure and error correction to HMRC. The error related to the partial exemption methodology and resulted in an underpayment of VAT over a historical period. Rotherwood Healthcare Limited forms a VAT group with Rotherwood Training and Development Limited, and therefore, the VAT liability is recoverable against all companies within the VAT group on a joint and several basis. The total VAT obligations within the Group as at 31 March 2025 was £5,357,905.

At the time of signing the financial statements, HMRC has yet to conclude its review of the disclosure and has not issued a determination in respect of any potential penalties that may be applied. As such, there remains a potential liability for additional amounts, the quantum and likelihood of which cannot be reliably estimated at this stage, which the Company may be jointly and severally liable to in addition to the principal amount detailed above.

As at 31 March 2025 there is no outstanding cross guarantee with HSBC UK PLC. This guarantee, which existed at 31 March 2024, made Rotherwood Healthcare Limited jointly liable for any bank liabilities incurred within the Rotherwood Group and its subsidiaries. The total liability outstanding as at 31 March 2025 is £Nil (2024: £12,712,061).

Triodos Bank UK Limited registered a fixed and floating charge over certain property and undertakings of the Group and certain of its subsidiaries as security under an intergroup cross guarantee arrangement. The total liability outstanding as at 31 March 2025 is £12,891,696 (2024: £Nil).

The Parent Group has, since the reporting date, via a separate sub-group, secured a £5,500,000 loan facility which, together with ongoing working capital and the anticipated sale of two non-core land holdings, is expected to cover the VAT liabilities already included in the Parent Group’s financial statements, and any penalties that may be incurred.

25. TRANSACTIONS WITH DIRECTORS

At the year end the Company owed the directors £Nil (2024: £628,138) in the form of a director's loan account. The loan is interest free and has no fixed repayment terms.

26. RELATED PARTY DISCLOSURES

During the year, the Company purchased services amounting to £208,800 (2024 - £208,800) from other related parties.

Amounts owed to other related parties at the year end totalled £377,728 (2024 - £503,348).

Amounts owed from other related parties at the year end totalled £219,983 (2024 - £229,892).

Amounts owed to other related parties, included within trade creditors at the year end totalled £34,800
(2024: £34,000).

The wholly owned subsidiaries of the other members of the Group are exempt from the requirements of Financial Reporting Standard 102, section 33.1A to disclose transactions.

No other transactions with related parties were undertaken such as are required to be disclosed under Financial Reporting Standard 102, section 33.

All transactions are considered to be arm's length.

ROTHERWOOD HEALTHCARE LIMITED (REGISTERED NUMBER: 09521668)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

27. POST BALANCE SHEET EVENTS

Post year-end, the HSBC UK Bank PLC fixed and floating charge over all property and undertakings of the Company was satisfied.

On 1 August 2025, the Company sold an investment property for proceeds of £730,000. No adjustment has been made to these financial statements in respect of this sale.

28. ULTIMATE CONTROLLING PARTY

The parent preparing consolidated accounts for the smallest and largest Group of which the Company is a member is Rotherwood Group Limited. The registered office is 11 Merus Court, Meridian Business Park, Leicester, LE19 1RJ.

29. PRIOR YEAR ADJUSTMENTS

During the year, the directors identified that prior year debtor and creditor balances were misclassified. Amounts owed from related parties of £229,892 had been included within amounts owed by group undertakings instead of other debtors. Amounts owed to related parties of £503,348 had been included within amounts owed to group undertakings instead of other creditors. These balances have now been restated to other debtors and other creditors respectively in the prior year comparatives. The related party disclosures in respect of amounts owed from related parties remain unchanged, as the prior year note correctly identified the balance as owed from other related parties.

Comparative figures have also been restated to improve the presentation of cost of sales. Subcontract labour of £891,103, previously included within gross wages, is now shown separately. Wages are paid by another subsidiary in the Group and, accordingly, employee costs disclosed in note 4 are £Nil for the prior period.

The above adjustments are presentational reclassifications and disclosure corrections only and have no impact on net assets, profit or loss or opening retained earnings.